This test can detect tiny ovarian tumors sooner than current tests

Massachusetts Institute of Technology engineers have developed a way to detect ovarian tumors that are smaller than 2 mm in diameter, allowing for detection 5 months earlier than existing tests.

A synthetic biomarker, which is a nanoparticle that works with tumor proteins to release fragments into the urine for detection, helps the MIT-developed test create a much clearer signal that natural biomarkers in the bloodstream don’t offer.

Get the full story on our sister site, Medical Design & Outsourcing.

The post This test can detect tiny ovarian tumors sooner than current tests appeared first on MassDevice.